SWOT Analysis for AstraZeneca Pharma India Ltd.

MACD Crossover Above Signal Line
Companies with no Debt
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Strong Annual EPS Growth
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every Quarter for the past 4 Quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
RSI indicating price strength
MACD crossed above signal line previous end of day
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter

PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Declining Net Cash Flow : Companies not able to generate net cash
Major fall in TTM Net Profit
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV

FII / FPI or Institutions increasing their shareholding

Companies with high market cap, lower public shareholding
MFs decreased their shareholding last quarter

Stocks in PE Buy Zone with Reasonable Durability Score, and Rising Momentum Score
Bullish or Bearish Candlestick Strength - Indices
Upside Tasuki Gap (Bullish Continuation)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Declining Net Cash Flow and Cash from Operating Activity for last 2 years
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)

AstraZeneca Pharma India Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats